+161.9%
MRNA vs IRM
+98.4%
+63.5%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | IRM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -0.7% | -3.2% | -3.8% |
| 7D | -17.6% | +0.9% | -18.5% | -17.7% |
| 30D | -5.1% | -0.6% | -4.5% | -4.8% |
| 3M | +220.8% | -13.3% | +234.1% | +226.8% |
| 6M | +321.7% | -9.3% | +331.0% | +321.7% |
| YTD | +601.3% | +37.9% | +563.4% | +506.4% |
| 1Y | +735.2% | +30.3% | +704.9% | +633.8% |
| All | +161.9% | +98.4% | +63.5% | +57.0% |
Cumulative growth
Daily Returns
Daily percentage return beside IRM.
Daily Out/Under-Performance
Portfolio return minus IRM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IRM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded IRM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling